165 related articles for article (PubMed ID: 33871586)
1. Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature.
Lobbes H; Mahévas M; Alviset S; Galicier L; Costedoat-Chalumeau N; Amoura Z; Alric L; Hot A; Durupt S; Michel M; Godeau B
Rheumatology (Oxford); 2021 Dec; 61(1):355-366. PubMed ID: 33871586
[TBL] [Abstract][Full Text] [Related]
2. Adult pure red cell aplasia at Universitas Academic Hospital, Bloemfontein, South Africa: A 9-year review.
Thibile S; Barrett C; Potgieter S; Joubert G; Malherbe J
S Afr Med J; 2022 Aug; 112(9):753-759. PubMed ID: 36214038
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of pure red cell aplasia with plasmapheresis in a patient with systemic lupus erythematosus.
Choi BG; Yoo WH
Yonsei Med J; 2002 Apr; 43(2):274-8. PubMed ID: 11971224
[TBL] [Abstract][Full Text] [Related]
4. Pure red cell aplasia and lupus.
Habib GS; Saliba WR; Froom P
Semin Arthritis Rheum; 2002 Feb; 31(4):279-83. PubMed ID: 11836661
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus with pure red cell aplasia: a case report.
Tsai MH; Lee DT; Chen HC; Hsueh SC; Tseng CP
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Oct; 52(4):265-8. PubMed ID: 8258121
[TBL] [Abstract][Full Text] [Related]
6. Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis.
Nakamura H; Okada A; Kawakami A; Yamasaki S; Ida H; Motomura M; Imanishi D; Eguchi K
Rheumatol Int; 2010 Nov; 30(12):1643-5. PubMed ID: 19705120
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Fujisawa S; Yonemura Y; Kawano F; Oshimi K; Sugimoto K; Matsuda A; Karasawa M; Arai A; Komatsu N; Harigae H; Omine M; Ozawa K; Kurokawa M;
Br J Haematol; 2015 Jun; 169(6):879-86. PubMed ID: 25807974
[TBL] [Abstract][Full Text] [Related]
8. Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.
Zhang M; Zhong X; Zhang W; Xu J; Zhang M; Shen Y; Wang W; Zheng S
Int J Clin Pract Suppl; 2015 May; (183):29-34. PubMed ID: 26177162
[TBL] [Abstract][Full Text] [Related]
9. [Pure red cell aplasia: Diagnosis, classification and treatment].
Lobbes H
Rev Med Interne; 2023 Jan; 44(1):19-26. PubMed ID: 36336519
[TBL] [Abstract][Full Text] [Related]
10. [A case of systemic lupus erythematosus accompanied with pure red cell aplasia].
Minami R; Izutsu K; Miyamura T; Yamamoto M; Suematsu E
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):148-53. PubMed ID: 16819263
[TBL] [Abstract][Full Text] [Related]
11. A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.
Ideguchi H; Ohno S; Ishigatsubo Y
Rheumatol Int; 2007 Feb; 27(4):411-4. PubMed ID: 17028860
[TBL] [Abstract][Full Text] [Related]
12. A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: response to rituximab and cyclophosphamide.
Gupta RK; Ezeonyeji AN; Thomas AS; Scully MA; Ehrenstein MR; Isenberg DA
Lupus; 2011 Dec; 20(14):1547-50. PubMed ID: 21993386
[TBL] [Abstract][Full Text] [Related]
13. [Pure red cell aplasia induced by clomipramine hydrochloride in a patient with SLE].
Sato T; Kogawa K; Hirayama Y; Sato Y; Nobuoka A; Kuribayashi K; Iyama S; Takada K; Hagiwara S; Takahashi S; Kato J; Sakamaki S; Ishigaki S; Niitsu Y
Rinsho Ketsueki; 2000 Aug; 41(8):648-52. PubMed ID: 11020992
[TBL] [Abstract][Full Text] [Related]
14. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group.
Hirokawa M; Sawada K; Fujishima N; Nakao S; Urabe A; Dan K; Fujisawa S; Yonemura Y; Kawano F; Omine M; Ozawa K;
Haematologica; 2008 Jan; 93(1):27-33. PubMed ID: 18166782
[TBL] [Abstract][Full Text] [Related]
15. The clinical characteristics and therapy response of patients with acquired pure red cell aplasia.
Fu R; Zhang T; Liu B; Song J; Wang G; Li L; Wang H; Xing L; Wu Y; Guan J; Shao Z
Hematology; 2018 Oct; 23(9):639-645. PubMed ID: 29754581
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
Crabol Y; Terrier B; Rozenberg F; Pestre V; Legendre C; Hermine O; Montagnier-Petrissans C; Guillevin L; Mouthon L;
Clin Infect Dis; 2013 Apr; 56(7):968-77. PubMed ID: 23243178
[TBL] [Abstract][Full Text] [Related]
17. [A case of systemic lupus erythematosus with pure red cell aplasia possibly caused by persistent infection of human parvovirus B 19].
Mitsunaka H; Tokuda M; Takahara J; Matoba K; Miyawaki S
Nihon Rinsho Meneki Gakkai Kaishi; 1998 Dec; 21(5):220-5. PubMed ID: 11155595
[TBL] [Abstract][Full Text] [Related]
18. Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin.
Ilan Y; Naparstek Y
Acta Haematol; 1993; 89(3):152-4. PubMed ID: 8362604
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcomes of 11 patients with pure red cell aplasia at a single institution over a 13-year period.
Kawano N; Nagahiro Y; Yoshida S; Yamashita K; Himeji D; Yokota-Ikeda N; Uezono S; Shimao Y; Makino S; Shimoda K; Ueda A
Intern Med; 2013; 52(18):2025-30. PubMed ID: 24042508
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group.
Sawada K; Hirokawa M; Fujishima N; Teramura M; Bessho M; Dan K; Tsurumi H; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2007 Aug; 92(8):1021-8. PubMed ID: 17640861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
